Back

Current and future treatment strategies to lower lipoprotein(a) .

26 August 2018 (13:34 - 13:51)
Organised by:
Congress Presentation Part of: Cardiovascular risk reduction and the role of lipoprotein(a): present and future therapeutic options Lipids ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Steven E Nissen

Cleveland Clinic Hospital, Cleveland (United States of America)

3 More presentations in this session

Presentation thumbnail
Basic science and mechanism of action of lipoprotein(a).
Professor S. Tsimikas (La Jolla, US)
Presentation thumbnail
Epidemiology and clinical trial data of lipoprotein(a).
Doctor L. Cho (Cleveland, US)
Presentation thumbnail
Panel discussion and Q&A.

Access the full session

Session thumbnail
Cardiovascular risk reduction and the role of lipoprotein(a): present and future therapeutic options

The Event

Event poster

ESC Congress 2018

26 August 2018 13:34 CET
You may be interested in
thumbnail
Congress Presentation
Review on clinical strategies for managing patients with elevated Lp(a): Cost-effectiveness of Lp(a) testing and awareness of lifestyle changes via Public Health Policy in absence of targeted therapy
24 June 2023
thumbnail
Congress Presentation
How to manage lipid risk pharmacologically – new approaches
13 April 2023
thumbnail
Congress Presentation
Time course of LDL-C lowering after initiation of PCSK9 inhibition or bempedoic acid in atherosclerotic cardiovascular disease
20 March 2026
thumbnail
Congress Presentation
Impact of lipoprotein(a) as a residual risk on long-term cardiovascular outcomes in patients with acute coronary syndrome treated with statin
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources